Documentation of Coverage Requirements for Medicare Home Health Claims

Inbunden, Engelska, 2025

Av Daniel R Levinson

389 kr

Beställningsvara. Skickas inom 7-10 vardagar

Fri frakt för medlemmar vid köp för minst 249 kr.

Finns i fler format (1)

199 kr

Skickas inom 7-10 vardagar

Produktinformation

Utgivningsdatum2025-05-22
Mått156 x 234 x 6 mm
Vikt218 g
FormatInbunden
SpråkEngelska
Antal sidor26
FörlagHutson Street Press
ISBN9781025062471

Tillhör följande kategorier

Ekonomisk politik inom Ekonomi och ledarskap
Hälso- och sjukvårdsrätt inom Juridik

Mer från samma författare

Deficiencies in the Oversight of the 340B Drug Pricing Program

Deficiencies in the Oversight of the 340B Drug Pricing Program

Daniel R Levinson

529 kr

Beneficiary Utilization of Albuterol and Levalbuterol Under Medicare Part B

Beneficiary Utilization of Albuterol and Levalbuterol Under Medicare Part B

Daniel R Levinson

389 kr

Deficiencies in the Oversight of the 340B Drug Pricing Program

Deficiencies in the Oversight of the 340B Drug Pricing Program

Daniel R Levinson

329 kr

Beneficiary Utilization of Albuterol and Levalbuterol Under Medicare Part B

Beneficiary Utilization of Albuterol and Levalbuterol Under Medicare Part B

Daniel R Levinson

199 kr

Use of Modifier 59 to Bypass Medicare's National Correct Coding Initiative Edits

Use of Modifier 59 to Bypass Medicare's National Correct Coding Initiative Edits

Daniel R Levinson

279 kr

Documentation of Coverage Requirements for Medicare Home Health Claims

Documentation of Coverage Requirements for Medicare Home Health Claims

Daniel R Levinson

339 kr

Retail Pharmacies with Questionable Part D Billing

Retail Pharmacies with Questionable Part D Billing

Daniel R Levinson

279 kr

Deficiencies in the Oversight of the 340b Drug Pricing Program

Deficiencies in the Oversight of the 340b Drug Pricing Program

Daniel R Levinson

339 kr

Intravenous Immune Globulin

Intravenous Immune Globulin

Daniel R Levinson

339 kr

Beneficiary Utilization of Albuterol and Levalbuterol Under Medicare Part B

Beneficiary Utilization of Albuterol and Levalbuterol Under Medicare Part B

Daniel R Levinson

339 kr

Du kanske också är intresserad av

Documentation of Coverage Requirements for Medicare Home Health Claims

Documentation of Coverage Requirements for Medicare Home Health Claims

Daniel R Levinson

199 kr

Deficiencies in the Oversight of the 340B Drug Pricing Program

Deficiencies in the Oversight of the 340B Drug Pricing Program

Daniel R Levinson

329 kr

Beneficiary Utilization of Albuterol and Levalbuterol Under Medicare Part B

Beneficiary Utilization of Albuterol and Levalbuterol Under Medicare Part B

Daniel R Levinson

199 kr

Food and Drug Administration's Oversight of Clinical Trials

Food and Drug Administration's Oversight of Clinical Trials

Daniel R Levinson

339 kr

Food and Drug Administration's Generic Drug Review Process

Food and Drug Administration's Generic Drug Review Process

Daniel R Levinson

279 kr

Documentation of Coverage Requirements for Medicare Home Health Claims - Scholar's Choice Edition

Documentation of Coverage Requirements for Medicare Home Health Claims - Scholar's Choice Edition

Daniel R Levinson

339 kr

Beneficiary Utilization of Albuterol and Levalbuterol Under Medicare Part B

Beneficiary Utilization of Albuterol and Levalbuterol Under Medicare Part B

Daniel R Levinson

389 kr

Food and Drug Administration's National Drug Code Directory

Food and Drug Administration's National Drug Code Directory

Daniel R Levinson

339 kr

Deficiencies in the Oversight of the 340B Drug Pricing Program - Scholar's Choice Edition

Deficiencies in the Oversight of the 340B Drug Pricing Program - Scholar's Choice Edition

Daniel R Levinson, Daniel R. Levinson, Office Of Inspector General (Oig), Us Department Of Health And Human Servic

339 kr

Use of Modifier 59 to Bypass Medicare's National Correct Coding Initiative Edits

Use of Modifier 59 to Bypass Medicare's National Correct Coding Initiative Edits

Daniel R Levinson

279 kr